Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Sio Gene Therapies stock

Learn how to easily invest in Sio Gene Therapies stock.

Sio Gene Therapies Inc is a biotechnology business based in the US. Sio Gene Therapies shares (SIOX) are listed on the NASDAQ and all prices are listed in US Dollars. Sio Gene Therapies employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Sio Gene Therapies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SIOX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Sio Gene Therapies stock price (NASDAQ: SIOX)

Use our graph to track the performance of SIOX stocks over time.

Sio Gene Therapies shares at a glance

Information last updated 2022-06-25.
Latest market close$0.37
52-week range$0.23 - $2.95
50-day moving average $0.38
200-day moving average $1.13
Wall St. target price$2.80
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.98

Buy Sio Gene Therapies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sio Gene Therapies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sio Gene Therapies price performance over time

Historical closes compared with the close of $0.3691 from 2022-07-01

1 week (2022-06-24) 11.85%
1 month (2022-06-02) 11.17%
3 months (2022-04-01) -47.35%
6 months (2021-12-31) -71.39%
1 year (2021-07-02) -85.80%
2 years (2020-07-02) -86.58%
3 years (2019-07-02) 6.29
5 years (2017-06-30) 23.19

Sio Gene Therapies financials

Gross profit TTM $0
Return on assets TTM -41.36%
Return on equity TTM -78.26%
Profit margin 0%
Book value $0.82
Market capitalisation $24.3 million

TTM: trailing 12 months

Sio Gene Therapies share dividends

We're not expecting Sio Gene Therapies to pay a dividend over the next 12 months.

Have Sio Gene Therapies's shares ever split?

Sio Gene Therapies's shares were split on a 1:8 basis on 7 May 2019. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sio Gene Therapies shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Sio Gene Therapies shares which in turn could have impacted Sio Gene Therapies's share price.

Sio Gene Therapies share price volatility

Over the last 12 months, Sio Gene Therapies's shares have ranged in value from as little as $0.23 up to $2.95. A popular way to gauge a stock's volatility is its "beta".

SIOX.US volatility(beta: 1.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sio Gene Therapies's is 1.8807. This would suggest that Sio Gene Therapies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Sio Gene Therapies overview

Sio Gene Therapies, Inc. , a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020.

Frequently asked questions

What percentage of Sio Gene Therapies is owned by insiders or institutions?
Currently 25.634% of Sio Gene Therapies shares are held by insiders and 26.711% by institutions.
How many people work for Sio Gene Therapies?
Latest data suggests 12 work at Sio Gene Therapies.
When does the fiscal year end for Sio Gene Therapies?
Sio Gene Therapies's fiscal year ends in March.
Where is Sio Gene Therapies based?
Sio Gene Therapies's address is: 130 West 42nd Street, New York, NY, United States, 10036
What is Sio Gene Therapies's ISIN number?
Sio Gene Therapies's international securities identification number is: US8293991043

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site